Table 1 Demographics across control and CSC cohorts.
Controls | CSC | |||
---|---|---|---|---|
All Patients | All Patients | Chronic | Acute | |
N (male/female) | 247 (69/178) | 109 (70/39) | 88 (57/31) | 21 (13/8) |
Age years (mean, SD) | 52 (13) | 54 (12) | 56 (11) | 49 (12) |
BCVA | ||||
Mean, SD | N/A | 0.060 (0.253) | 0.0823 (0.266) | ‒0.0280 (0.152)1 |
Missing | N/A | 1 | 0 | |
BMI (mean, SD) | 27.0 (6.92) | 26.2 (5.94) | 26.2 (6.10) | 25.7 (5.28) |
Missing | 10 | 3 | 1 | 1 |
Global PSQI | 5.59 (3.24) | 5.26 (3.37) | 5.32 (3.60) | 4.90 (2.02) |
Sleep quality | 1.081 (0.739) | 1.08 (0.73) | 1.09 (0.748) | 1.05 (0.686) |
Sleep latency | 0.773 (0.719) | 0.648 (0.674) | 0.671 (0.690) | 0.600 (0.598) |
Sleep duration | 0.709 (0.853) | 0.704 (0.889) | 0.739 (0.941) | 0.500 (0.607) |
Sleep efficiency | 0.761 (1.01) | 0.824 (0.994) | 0.852 (1.034) | 0.600 (0.754) |
Sleep disturbance | 1.33 (0.551) | 1.21 (0.513) | 1.23 (0.541) | 1.15 (0.366) |
Sleep medication | 0.174 (0.617) | 0.157 (0.614) | 0.171 (0.665) | 0.050 (0.224) |
Daytime dysfunction | 0.757 (0.753) | 0.657 (0.787) | 0.602 (0.796) | 0.950 (0.686) |
ESS | 6.37 (4.21) | 5.78 (3.91) | 5.89 (3.98) | 5.53 (3.55) |
HADS | 8.58 (6.04) | 8.14 (5.20) | 8.30 (5.37) | 7.53 (4.39) |
HADS-A | 5.52 (3.61) | 5.37 (3.42) | 5.39 (3.52) | 5.21 (2.97) |
HADS-D | 3.05 (3.03) | 2.76 (2.63) | 2.90 (2.70) | 2.32 (2.34) |
MEQ (chronotype) | 60.4 (9.41) | 62.3 (8.96) | 62.4 (9.01) | 62.7 (9.21) |
MET (diurnal preference) | 1.59 (0.983) | 1.39 (0.979) | 1.38 (0.975) | 1.37 (1.06) |
Physical function | 84.7 (21.6) | 90.1 (16.2) | 88.9 (17.4) | 95.0 (7.07) |
Emotional wellbeing | 76.6 (16.5) | 77.7 (14.2) | 79.00 (14.3) | 72.00 (12.2) |
Social functioning | 88.1 (19.8) | 90.1 (19.9) | 89.9 (19.4) | 89.5 (22.5) |
Pain | 80.5 (22.0) | 83.8 (22.1) | 84.0 (22.4) | 83.6 (21.1) |
General health | 70.9 (19.7) | 72.9(18.4) | 72.2 (18.1) | 76.3 (19.9) |